QCI ASSET MANAGEMENT INC/NY - INNATE IMMUNOTHERAPEUTICS LT ownership

Back to all holdings Add to watchlist

INNATE IMMUNOTHERAPEUTICS LT's ticker is and the CUSIP is Q4934F101. A total of 1 filers reported holding INNATE IMMUNOTHERAPEUTICS LT in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
QCI ASSET MANAGEMENT INC/NY ownership history of INNATE IMMUNOTHERAPEUTICS LT
ValueSharesWeighting
Q2 2018$13,000
-62.9%
60,000
-90.0%
0.00%
-75.0%
Q1 2018$35,000
+400.0%
600,000
+100.0%
0.00%
+300.0%
Q4 2017$7,000–300,000–0.00%–
 Download
Other shareholders
INNATE IMMUNOTHERAPEUTICS LT shareholders Q1 2018
NameSharesValueWeighting ↓
QCI ASSET MANAGEMENT INC/NY 300,000$7,0000.00%
View complete list of INNATE IMMUNOTHERAPEUTICS LT shareholders